Recomendaciones para la práctica (Parte 1) | 13 AGO 12

Guía para el control de Enterobacterias resistentes al Carbapenem

Recomendaciones para los servicios de atención de la salud. el Control de las enterobacterias productoras de carbapenemasa o resistentes al carbapenem en servicios de atención de enfermos agudos.
INDICE:  1. Referencias | 2. Referencias
Referencias

Referencias seleccionadas

Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the controlof a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.Infect Control Hosp Epidemiol 2010 Jun;31(6):620-6.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty Second Informational Supplement(January 2012). CLSI document M100-S22. Wayne, Pennsylvania, 2012.

Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009 May;30(5):447-52.

Munoz-Price LS, De La Cuesta C, Adams S, et al. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 2010 Oct;31(10):1074-7.

Munoz-Price LS, Hayden MK, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010 Apr;31(4):341-7.

Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcusin health care facilities in a region. N Engl J Med 2001;344(19):1427-33.

Schechner V, Kotlovsky T, Tarabeia J, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011 May;32(5):497-503.

Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008 Dec;29(12):1099-106.

Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008 Mar;52(3):1028-33.

Schwaber MJ, Lev B, Israeli A, et al. Containment of a Country-wide Outbreakof Carbapenem-resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention. Clin Infect Dis 2011 Feb 11.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024